Clinical Trial Update: Efficacy and Tolerability Study of Two Dosing Regimens of CTP-543 in Adults With Alopecia Areata [Phase 2]

View source ↗

Summary

Phase 2 trial assessing two dosing regimens of CTP-543 for efficacy and tolerability in adults with alopecia areata; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alopecia Areata

Drugs mentioned

• CTP-543

Snippet

Sponsor: Concert Pharmaceuticals | Conditions: Alopecia Areata | Phase 2 | Status: COMPLETED | Results posted: 2023-04-05